Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
98,656,192
-
Total 13F shares
-
1,599,991
-
Share change
-
+1,599,991
-
Total reported value
-
$6,600,000
-
Price per share
-
$4.14
-
Number of holders
-
18
-
Value change
-
+$6,600,002
-
Number of buys
-
18
Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q3 2021
As of 30 Sep 2021,
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,599,991 shares.
The largest 10 holders included
Mirae Asset Global Investments Co., Ltd., RENAISSANCE TECHNOLOGIES LLC, JANE STREET GROUP, LLC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, Vident Investment Advisory, LLC, TWO SIGMA ADVISERS, LP, MORGAN STANLEY, Marble Harbor Investment Counsel, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.